Defunct Company
Total Trials
9
As Lead Sponsor
0
As Collaborator
Total Enrollment
443
NCT02778113
A Study of Glucagon Administered in Different Forms and Routes to Healthy Adults
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2011
Completion: Nov 30, 2011
NCT01556594
Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced Hypoglycemia
Phase: Phase 2
Start: Mar 31, 2012
Completion: Jul 31, 2012
NCT02778100
A Study of Nasal Glucagon in Participants With a Common Cold
Start: Mar 31, 2013
Completion: Apr 30, 2013
NCT01959334
Evaluate the Immunogenicity of a Novel Glucagon Formulation
Phase: Phase 3
Start: Sep 30, 2013
Completion: Dec 31, 2013
NCT01994746
Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
Start: Nov 30, 2013
Completion: Jan 31, 2015
NCT01997411
Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
Phase: Phase 2/3
NCT02171130
Clinical Usability of Intranasal Glucagon in Treatment of Hypoglycemia
Start: May 31, 2014
Completion: Aug 31, 2015
NCT02806960
A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Start: Jun 30, 2014
Completion: Aug 31, 2014
NCT02806973
A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
Start: Jan 31, 2015
Completion: Apr 30, 2015